Other

Cash received from option exercises

West Pharmaceutical Services Cash received from option exercises increased by 77.4% to $5.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 120.0%, from $2.50M to $5.50M. Over 3 years (FY 2021 to FY 2025), Cash received from option exercises shows a downward trend with a -27.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Higher proceeds indicate active participation in equity incentive plans, which can signal employee confidence in the company's future stock performance.

Detailed definition

Cash received by the company from employees or directors exercising their vested stock options. This reflects the liquid...

Peer comparison

Common in companies with significant stock-based compensation; varies based on stock price performance relative to exercise prices.

Metric ID: other_proceeds_from_stock_options_exercised

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$12.00M$5.30M$6.30M$6.40M$3.80M$13.50M$10.50M$18.60M$1.30M$14.80M$5.10M$4.10M$1.50M$2.50M$3.50M$2.20M$3.10M$5.50M
QoQ Change-55.8%+18.9%+1.6%-40.6%+255.3%-22.2%+77.1%-93.0%>999%-65.5%-19.6%-63.4%+66.7%+40.0%-37.1%+40.9%+77.4%
YoY Change+20.8%-39.7%+190.6%-65.8%+9.6%-51.4%-78.0%+15.4%-83.1%-31.4%-46.3%+106.7%+120.0%
Range$1.30M$18.60M
CAGR-16.8%
Avg YoY Growth+5.2%
Median YoY Growth-31.4%
Current Streak2 quarters growth

Cash received from option exercises at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's cash received from option exercises?
West Pharmaceutical Services (WST) reported cash received from option exercises of $5.50M in Q1 2026.
How has West Pharmaceutical Services's cash received from option exercises changed year-over-year?
West Pharmaceutical Services's cash received from option exercises increased by 120.0% year-over-year, from $2.50M to $5.50M.
What is the long-term trend for West Pharmaceutical Services's cash received from option exercises?
Over 3 years (2021 to 2025), West Pharmaceutical Services's cash received from option exercises has grown at a -27.3% compound annual growth rate (CAGR), from $29.40M to $11.30M.
What does cash received from option exercises mean?
Cash inflow resulting from employees purchasing company stock through option plans.